chr7-90726583-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The ENST00000406263.5(CDK14):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
CDK14
ENST00000406263.5 start_lost
ENST00000406263.5 start_lost
Scores
5
7
7
Clinical Significance
Conservation
PhyloP100: 7.30
Genes affected
CDK14 (HGNC:8883): (cyclin dependent kinase 14) Enables cyclin binding activity and cyclin-dependent protein serine/threonine kinase activity. Involved in G2/M transition of mitotic cell cycle and regulation of canonical Wnt signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane. Part of cytoplasmic cyclin-dependent protein kinase holoenzyme complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK14 | NM_001287135.2 | c.140T>C | p.Met47Thr | missense_variant | 3/15 | ENST00000380050.8 | NP_001274064.1 | |
CDK14 | NM_001287136.1 | c.2T>C | p.Met1? | start_lost | 2/14 | NP_001274065.1 | ||
CDK14 | NM_012395.3 | c.86T>C | p.Met29Thr | missense_variant | 2/14 | NP_036527.1 | ||
CDK14 | NM_001287137.1 | c.-153T>C | 5_prime_UTR_variant | 2/13 | NP_001274066.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK14 | ENST00000380050.8 | c.140T>C | p.Met47Thr | missense_variant | 3/15 | 1 | NM_001287135.2 | ENSP00000369390 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.86T>C (p.M29T) alteration is located in exon 2 (coding exon 2) of the CDK14 gene. This alteration results from a T to C substitution at nucleotide position 86, causing the methionine (M) at amino acid position 29 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T;T;T;T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;.;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;T;D;T;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;.;N;.;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N;N;D;N;N
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D;T;D;D;D
Sift4G
Pathogenic
D;D;D;D;T;D;D;D
Polyphen
0.72, 0.81
.;.;.;.;P;.;P;.
Vest4
0.88, 0.79, 0.88
MutPred
0.16
.;.;.;.;Gain of phosphorylation at M47 (P = 0.0471);.;.;.;
MVP
MPC
0.67
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.